Education
About Us
Working with TipRanks
Follow Us
Summit Therapeutics (SMMT)
NASDAQ:SMMT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 704.29K | $ 1.81M | $ 860.00K |
| Gross Profit | $ -15.01M | $ -2.05M | $ -1.81M | $ 1.81M | $ 860.00K |
| Operating Income | $ 313.00K | $ -89.74M | $ -72.09M | $ -86.19M | $ -53.19M |
| EBITDA | $ 313.00K | $ 1.00M | $ -52.63M | $ -62.74M | $ -37.13M |
| Net Income | $ -221.31M | $ -614.93M | $ -74.38M | $ -86.15M | $ -52.70M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 412.35M | $ 186.24M | $ 348.61M | $ 71.79M | $ 66.42M |
| Total Assets | $ 435.56M | $ 202.95M | $ 664.17M | $ 113.37M | $ 102.50M |
| Total Debt | $ 7.22M | $ 106.10M | $ 518.76M | $ 2.78M | $ 465.00K |
| Net Debt | $ -97.64M | $ 34.67M | $ 170.16M | $ -69.01M | $ -65.95M |
| Total Liabilities | $ 46.81M | $ 125.26M | $ 537.51M | $ 30.09M | $ 23.05M |
| Stockholders' Equity | $ 388.75M | $ 77.69M | $ 126.65M | $ 83.28M | $ 79.45M |
| Cash Flow | |||||
| Free Cash Flow | $ -142.25M | $ -76.89M | $ -42.21M | $ -72.89M | $ -48.53M |
| Operating Cash Flow | $ -142.11M | $ -76.76M | $ -41.58M | $ -72.59M | $ -48.11M |
| Investing Cash Flow | $ -205.34M | $ -587.77M | $ -624.00K | $ -306.00K | $ -421.00K |
| Financing Cash Flow | $ 381.23M | $ 86.51M | $ 620.24M | $ 77.92M | $ 50.55M |